Researcher finds key to drug resistant bowel cancer
Blocking a molecule could bypass bowel cancer's defence against the drug cetuximab, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
Nov 8, 2016
0
122